详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Dongdong Xia[1] ; Enxin Wang[1] ; Qiuhe Wang[1] ; Wei Bai[1] ; Zhexuan Wang[1] ; Wei Mu[2] ; Junhui Sun[3] ; Ming Huang[4] ; Guowen Yin[5] ; Hailiang Li[6] ; Hui Zhao[7] ; Chunqing Zhang[8] ; Jing Li[9] ; Jianbing Wu[10] ; Xiaoli Zhu[11] ; Shufa Yang[12] ; Xingnan Pan[13] ; Jiaping Li[14] ; Zixiang Li[15] ; Guohui Xu[16]

; Haibin Shi[17] ; Wenjun Wang[1] ; Jing Niu[1] ; Jie Yuan[1] ; Xiaomei Li[1] ; Yong Lv[1] ; Kai Li[1] ; Zhanxin Yin[1] ; Daiming Fan[18] ; Jielai Xia[19] ; Guohong Han[1] ;

机构： [1]Department of Liver Disease and Digestive Interventional Radiology, National Clinical Research Centre for Digestive Disease and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China [2]Department of Radiology, the Southwest Hospital, Third Military Medical University, Chongqing, China [3]Department of Hepatobiliary and Pancreatic Interventional Cancer, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China [4]Department of Minimally Invasive International Therapy, the Third Affiliated Hospital of Kunming University, Tumour Hospital of Yunnan province, Kunming, China [5]Department of Interventional Radiology, Jiangsu Provincial Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China [6]Department of Interventional Radiology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China [7]Department of Interventional Radiology, the Affiliated Hospital of Nantong University, Nantong, China [8]Department of Gastroenterology and Hepatology, Shandong Province Hospital Affiliated to Shandong University, Jinan, China [9]Department of Hepatobiliary Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, China [10]Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang, China [11]Department of Interventional Radiology, the First Affiliated Hospital of Soochow University, Suzhou, China [12]Department of Interventional Radiology, the Affiliated Tumour Hospital of Xinjiang Medical University, Urumqi, China [13]Clinical Liver Diseases Research Centre, Nanjing Military Command, 180th Hospital of PLA, Quanzhou, China [14]Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China [15]Interventional Medical Centre of the Affiliated Hospital of Qingdao University, Qingdao, China [16]Department of Interventional Radiology, Sichuan Cancer Hospital and Institute, Chengdu, China [17]Department of Interventional Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China [18]State Key laboratory of Cancer Biology, National Clinical Research Centre for Digestive Disease and Xijing Hospital of Digestive Diseases,Fourth Military Medical University, Xi’an, China [19]Department of Health Statistics, Fourth Military Medical University, Xi'an, China

出处：

DOI：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

JCR分区：

出版当年[2019]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

最新[2023]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

第一作者：

第一作者机构： [1]Department of Liver Disease and Digestive Interventional Radiology, National Clinical Research Centre for Digestive Disease and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization

文献详情